Velusetrag

N/A

Report date: 2023/02/14 20:00:43
NME

Base Information

Drug NameVelusetrag
Drug Alias Namevelusetragum维司曲格维鲁司曲velusetragTD-5108
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 4 (5-HT4) receptor agonists
TargetsSerotonin 4 (5-HT4) receptor
Therapy Area/IndicationsConstipationAlzheimer DiseaseGastroparesis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesItaly +[4] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTheravance Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesAlfasigma Spa
Inactive CompaniesTheravance Biopharma Inc
Active IndicationsIntestinal Pseudo-Obstruction
Inactive IndicationsConstipationAlzheimer DiseaseGastroparesis

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG